MediXall Group Past Earnings Performance

Past criteria checks 0/6

MediXall Group has been growing earnings at an average annual rate of 27.1%, while the Healthcare Services industry saw earnings growing at 23.3% annually.

Key information

27.1%

Earnings growth rate

33.2%

EPS growth rate

Healthcare Services Industry Growth1.7%
Revenue growth raten/a
Return on equityn/a
Net Margin-2,213.2%
Last Earnings Update30 Sep 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How MediXall Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:MDXL Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 230-530
30 Jun 230-530
31 Mar 230-630
31 Dec 220-730
30 Sep 220-730
30 Jun 220-730
31 Mar 220-830
31 Dec 210-630
30 Sep 210-740
30 Jun 210-630
31 Mar 210-630
31 Dec 200-630
30 Sep 200-530
30 Jun 200-530
31 Mar 200-520
31 Dec 190-320
30 Sep 190-320
30 Jun 190-320
31 Mar 190-310
31 Dec 180-310
30 Sep 180-310
30 Jun 180-210
31 Mar 180-210
31 Dec 170-210
30 Sep 170-110
30 Jun 170-110
31 Mar 170-110
31 Dec 160-100

Quality Earnings: MDXL is currently unprofitable.

Growing Profit Margin: MDXL is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if MDXL's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare MDXL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MDXL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (17.5%).


Return on Equity

High ROE: MDXL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:27
End of Day Share Price 2024/11/21 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MediXall Group, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution